Panacea Biotec gets warning letter from USFDA for Baddi plant

05 Oct 2020 Evaluate

Panacea Biotec has received warning letter from US Food and Drug Administration (USFDA) for violating current good manufacturing practice norms at its Baddi plant in Himachal Pradesh. This warning letter summarises significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals. Because methods, facilities, or controls for manufacturing, processing, packing, or holding do not conform to CGMP, company’s drug products are adulterated. The significant violations included company's failure to establish laboratory controls.

Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

327.70 -4.25 (-1.28%)
02-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1752.70
Dr. Reddys Lab 1294.65
Cipla 1351.85
Zydus Lifesciences 906.85
Lupin 2311.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×